本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Kura Oncology, Inc

8.24
+0.10501.29%
成交量:65.35萬
成交額:542.94萬
市值:7.15億
市盈率:-3.65
高:8.48
開:8.15
低:8.15
收:8.13
52周最高:21.40
52周最低:5.41
股本:8,679.72萬
流通股本:6,398.56萬
量比:0.41
換手率:1.02%
股息:- -
股息率:- -
每股收益(TTM):-2.2592
每股收益(LYR):-2.0193
淨資產收益率:-51.11%
總資產收益率:-22.93%
市淨率:2.34
市盈率(LYR):-4.08

資料載入中...

2023/08/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/03

重要事件披露

Form 8-K - Current report
2023/06/15

重要事件披露

Form 8-K - Current report
2023/06/12

重要事件披露

Form 8-K - Current report
2023/06/02

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/06/02

重要事件披露

Form 8-K - Current report
2023/05/10

重要事件披露

Form 8-K - Current report
2023/05/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/19

重要事件披露

8-K - Current report
2023/03/10

重要事件披露

8-K - Current report
2023/02/24

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/23

重要事件披露

8-K - Current report
2023/02/23

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals